
KEY TAKEAWAYS: The progression of multiple sclerosis is particularly difficult to predict, varying widely between patients A new blood test uses a biomarker of nerve cell damage to accurately predict progression over the next two years If the test proves valid, it might help patients and their doctor plan optimal treatments, the researchers said One… read on > read on >